182 related articles for article (PubMed ID: 19234881)
1. Bone defects following curettage do not necessarily need augmentation.
Hirn M; de Silva U; Sidharthan S; Grimer RJ; Abudu A; Tillman RM; Carter SR
Acta Orthop; 2009 Feb; 80(1):4-8. PubMed ID: 19234881
[TBL] [Abstract][Full Text] [Related]
2. Time to full weight-bearing with the use of a calcium sulfate-calcium phosphate bone substitute as a bone void filler following extended curettage in the treatment of primary benign bone tumours.
Gyemi L; Selznick A; Petrisor B; Ghert M
J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254200. PubMed ID: 38733211
[TBL] [Abstract][Full Text] [Related]
3. Early postoperative compilations of bone filling in curettage defects.
Chen CJ; Brien EW
J Orthop Surg Res; 2019 Aug; 14(1):261. PubMed ID: 31419993
[TBL] [Abstract][Full Text] [Related]
4. [Lyophilized small-segment allogeneic bone in repairing bone defect due to benign bone tumor and tumor-like lesions after resection and curettage].
Guo S; Feng W; Jia Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):789-92. PubMed ID: 17882868
[TBL] [Abstract][Full Text] [Related]
5. Curettage of benign bone tumors and tumor like lesions: A retrospective analysis.
Kundu ZS; Gupta V; Sangwan SS; Rana P
Indian J Orthop; 2013 May; 47(3):295-301. PubMed ID: 23798762
[TBL] [Abstract][Full Text] [Related]
6. Grafting for bone defects after curettage of benign bone tumor - Analysis of factors influencing the bone healing.
Wu PK; Chen CF; Chen CM; Tsai SW; Cheng YC; Chang MC; Chen WM
J Chin Med Assoc; 2018 Jul; 81(7):643-648. PubMed ID: 29789225
[TBL] [Abstract][Full Text] [Related]
7. Treatment alternatives and clinical outcomes of bone filling after benign tumour curettage. A systematic review.
Gava NF; Engel EE
Orthop Traumatol Surg Res; 2022 Jun; 108(4):102966. PubMed ID: 34033919
[TBL] [Abstract][Full Text] [Related]
8. Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series.
Perisano C; Barone C; Stomeo D; Di Giacomo G; Vasso M; Schiavone Panni A; Maccauro G
J Orthop Traumatol; 2016 Dec; 17(4):377-382. PubMed ID: 27394916
[TBL] [Abstract][Full Text] [Related]
9. Filling of the resultant cavity after curettage of benign bone tumours is still controversial.
Ismail TB; Mahmoud MM; Ahmed OE; Bola AH; Bahaa ZH
Med J Malaysia; 2023 Mar; 78(2):163-170. PubMed ID: 36988525
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX®.
Friesenbichler J; Maurer-Ertl W; Sadoghi P; Pirker-Fruehauf U; Bodo K; Leithner A
Clin Orthop Relat Res; 2014 Mar; 472(3):976-82. PubMed ID: 24078171
[TBL] [Abstract][Full Text] [Related]
11. "Three-in-One minimally invasive approach to surgical treatment of pediatric pathological fractures with wide bone loss through bone cysts: ESIN, curettage and packing with injectable HA bone substitute. A retrospective series of 116 cases.".
Guida P; Ragozzino R; Sorrentino B; Casaburi A; D'Amato RD; Federico G; Guida L; Assantino A
Injury; 2016 Jun; 47(6):1222-8. PubMed ID: 27105837
[TBL] [Abstract][Full Text] [Related]
12. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction.
Horstmann PF; Hettwer WH; Petersen MM
J Orthop Surg (Hong Kong); 2018; 26(3):2309499018774929. PubMed ID: 30428758
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
Cao W; Ye Z; Lin N; Liu M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
[TBL] [Abstract][Full Text] [Related]
14. A comparative study for the treatment of simple bone cysts of the humerus: open curettage and bone grafting either without instrumentation or with intramedullary nailing.
Erol B; Onay T; Topkar OM; Tokyay A; Aydemir AN; Okay E
J Pediatr Orthop B; 2017 Jan; 26(1):5-13. PubMed ID: 27341120
[TBL] [Abstract][Full Text] [Related]
15. Curettage and graft alleviates athletic-limiting pain in benign lytic bone lesions.
Moretti VM; Slotcavage RL; Crawford EA; Lackman RD; Ogilvie CM
Clin Orthop Relat Res; 2011 Jan; 469(1):283-8. PubMed ID: 20461483
[TBL] [Abstract][Full Text] [Related]
16. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
[TBL] [Abstract][Full Text] [Related]
17. A novel subchondral bone-grafting procedure for the treatment of giant-cell tumor around the knee: A retrospective study of 27 cases.
Wu M; Yao S; Xie Y; Yan F; Deng Z; Lei J; Cai L
Medicine (Baltimore); 2018 Nov; 97(45):e13154. PubMed ID: 30407342
[TBL] [Abstract][Full Text] [Related]
18. Curettage of benign bone tumors without grafts gives sufficient bone strength.
Yanagawa T; Watanabe H; Shinozaki T; Takagishi K
Acta Orthop; 2009 Feb; 80(1):9-13. PubMed ID: 19234882
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of benign lesions and pathologic fractures of the proximal femur in children.
Tomaszewski R; Rutz E; Mayr J; Dajka J
Arch Orthop Trauma Surg; 2022 Apr; 142(4):615-624. PubMed ID: 33236185
[TBL] [Abstract][Full Text] [Related]
20. Aqueous calcium sulphate as bone graft for voids following open curettage of bone tumours.
Johnson LJ; Clayer M
ANZ J Surg; 2013 Jul; 83(7-8):564-70. PubMed ID: 22925525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
